Carl Zeiss Meditec and Optovue Settle Dispute
DUBLIN, Calif. & FREMONT, Calif.--(BUSINESS WIRE)--Carl Zeiss Meditec Inc. (CZMI) and Optovue Corp. announced that the parties have resolved their legal disputes pending in the Northern
Read Full Article
Related Articles
- OCTANe Foundation for Innovation Grants $20,000 Innovation Award also published in businesswire.com
- Relation of optical coherence tomography and unusual angiographic leakage patterns in central serous chorioretinopathy also categorized in Ophthalmology
- High efficiency low coherence interferometry also mentions Optovue
- Change of foveal and perifoveal thickness measured by OCT after phacoemulsification and IOL implantation also categorized in Ophthalmology
- Automatic retinal blood flow calculation using spectral domain optical coherence tomography also categorized in Ophthalmology
- Correlation between microaneurysm closure rate and reduction in macular thickness following laser photocoagulation of diabetic macular edema also categorized in Ophthalmology
- In vivo measurements of macular and nerve fibre layer thickness in retinal arterial occlusion also categorized in Ophthalmology
- GlucoLight Corporation Raises Second Tranche of ''c'' Round Financing also published in businesswire.com
- GlucoLight Corporation Raises Second Tranche of “c” Round Financing also published in businesswire.com
- Assessment of macular function by microperimetry in unilateral resolved central serous chorioretinopathy also categorized in Ophthalmology
Login to comment.